The lymphatic system has three main functions: it preserves fluid balance within the body; it has an important role in the body's defence mechanism; and the intestinal lymphatics are responsible for fat absorption (Mortimer and Rockson 2014) . The lymphatic system can fail as a result of an overload of [Q interstitial?] fluid, caused by microvascular filtration or a transport capacity alteration such as surgical removal of the lymph nodes. Previously, absorption of 90% of the interstitial fluid was thought to exist [Q occur?] at the venous capillary end; however, this is now known to be directly linked to lymphatic drainage [Q is further explanation of this necessary here -would most nurses know what interstitial fluid is referring to here and its relevance to the lymphatic system? Also please add a reference for this sentence]. Mortimer and Rockson (2014) recommended that the presence of chronic oedema should be considered as synonymous with the presence of lymphedema, since all oedema represents relative lymph drainage failure.
[Q could a definition of 'wet legs' be added here, and how it relates to chronic oedema -is it a complication of chromic oedema or a separate condition? And could the more formal name 'lymphorrhoea' be used?]
Background
Chronic oedema and wet legs are frequently encountered in the community setting (For-Szabo and Ralph 2017), as a result of factors such as an ageing population, obesity, inactivity and people living with multiple comorbidities.
Research has indicated that up to 68% of community nurses' caseloads are patients with chronic oedema [Q please confirm this figure is correct -is this 68% all community nurses? If so, this seems very high!] (Moffatt 2017) . Chronic oedema and leaking legs [Q is this the same as wet legs? If so, suggest changing to wet legs for consistency] can have a significant and long-term effects on patients and can affect a range of outcomes, with potential physical, psychological and social effects on their health (Sneddon 2008, Watts and Davies 2016) . Managing chronic oedema can be a considerable financial burden to the NHS as a result of repeated hospital admissions, inappropriate use of dressings and nursing time (Moffatt et al 2003) . There is limited national guidance on the management of chronic oedema and wet legs in the community. While best practice guidance is available on compression therapy, they are not unique to [Q not specific to ?] managing wet legs in chronic oedema (Lymphoedema Framework 2006 , International Lymphoedema Framework 2012 , Wounds UK 2015 and they do not provide practical guidance for community nurses.
As a result of the lack of knowledge and understanding of chronic oedema, it is frequently unrecognised, resulting in diagnostic delays and, in some cases, inappropriate treatment (Thomas and Morgan 2017 
Skin care
Daily washing drying and application of emollients advised for all patients with or without [Q chronic?] oedema
Movement and exercise
All patients were given simple exercises to complete on a daily basis this included toe tapping, knee extension and flexion. This was supported by written leaflets and being prescribed a video film General advice on sleeping arrangements All patients were advised on the importance of going to bed for a minimum of 6-8 hours every day. If patients were unable to go to bed, the cause was investigated and the patient was signposted for support. If the patient continued to decline to go to bed then advice was given to elevate the legs as well as increasing the frequency of exercises This article discusses the results of a pilot service evaluation exploring the use of the OGEP to improve education and support proactive service delivery for patients with chronic oedema and wet legs.
Aim
The aim of the pilot service evaluation was to investigate the economic effects of the OGEP and its effects on patients' quality of life.
Method
The pilot service evaluation commenced in June 2016 in Cardiff and Vale University Health Board, where two lymphoedema clinical educators were employed to work directly with community nurses [Q where were the community nurses based -which service(s), and how many were involved in the OGEP?] for a nine-month
period. An observational study design was used. Baseline measurements of the use of resources, costs and outcomes for these patients were captured at the time they were initially identified, before the OGEP, and at a follow-up review (EUROQOL 2017) at baseline and at the three-month follow-up review. The EQ-5D 5L is a health-related quality of life tool used to capture patient-reported outcomes. Initially, patients are asked to report on their general health state concerning their mobility, self-care, usual activities, pain/discomfort and anxiety/depression on a scale of five levels from 'no problems' to 'extreme problems'. Each of these scores converts into an individual utility score that represents a patient's quality of life, and can be used for health economic evaluation to estimate quality-adjusted life years (QALYs). A Visual Analogue Scale distress thermometer [Q was the EQ VAS included as part of the EQ-5D
5L?] was also used, in which patients are asked to give a self-rated score of their health today on a scale of 0 (the worst health you can imagine) to 100 (the best health you can imagine).
[Q was consent required from patients to participate in the study?]
All data were fully anonymised and entered into a Microsoft Excel spreadsheet. As can be seen in Table 2 , there was a significant decrease in the number of district nurse home visits post-OGEP as well as GP surgery appointments, number of episodes of cellulitis and hospital admissions for cellulitis. Although the P values recorded are statistically significant at P=<0.005, caution should be taken given the small numbers in some of the categories. Nevertheless, there was an observed trend in reduced use of resources between the baseline and the three-month follow-up review. When reviewing the direct costs associated with the OGEP, it was identified that the largest differences between the outcomes at the baseline and the three-month follow-up review were in district nurse home visits; mean patient cost £1207.8 (SD £976.9) compared to £565.8 (SD £563.3); a difference of -£641.9; 95% CI (-£478.5; -£805.4) at the three-month follow-up review. Furthermore, there was a large difference in the costs of dressings, which were £52,419 at baseline compared to £19,667 post-OGEP [Q I'm not sure how these figures were determined -were these the dressing costs/district nurse visit costs over a particular time period before the OGEP, compared to another time period after the OGEP?]. Thus, there was a reduction in costs by 47% and 38% [Q please check these -I think the percentages for the reduction would be 53% and 62% ?] respectively. Since there was no randomised comparator, the authors cannot firmly indicate whether the cost reductions were a direct result of the OGEP; however, the authors propose that this initial pilot service evaluation may offer some evidence to support the benefits of the OGEP in contributing to potential cost reductions.
There was also an improvement noted in the EQ-5D-5L utility scores from 0.401 (SD 0.254) to 0.537 (SD 0.231) at the three-month follow-up review. The mean difference of 0.136 (95% CI -0.098-0.174) was statistically significant with a P value of <0.001. The results of the Visual Analogue Scale also showed an increase from 47.07 (SD 15.17) to 61.76 (SD 18.41) at the three-month follow-up review. The mean difference of 14.69 (CIs 10.75, 18.63) was also shown to be statistically significant (P value=<0.001). However, the evidence is from a pilot service evaluation and is at 'grass roots level' [Q thus further research is necessary?]. In addition to the possible overall cost savings to the NHS that the OGEP may provide for this patient group, there is a potential wider benefit in that patients with chronic oedema experienced significant quality of life improvements after receiving the OGEP.
Discussion
The findings indicated there were changes in the use of resources and costs when comparing the baseline and three months after the OGEP was implemented. There were clear reductions in district nurse home visits, number of episodes of cellulitis and dressing costs. This pilot service evaluation also indicated there were small but important patient health gains seen at the three-month follow-up review, compared to the baseline.
The OGEP model delivers education directly to the community nurses, challenges their practice, and enables time for facilitated reflection [Q it's not mentioned previously that the reflection was facilitated -was this facilitated by the lymphoedema clinical educators, and was it on an individual or group basis?]. Discussing the benefits and consequences of appropriate prescribing and chronic oedema management can enable nurses to reflect, which is particularly useful for validation [Q meaning unclear -is this referring to revalidation with the NMC?].
The OGEP could be regarded not only as an educational intervention, but also as a means of challenging and changing [Q community nurses' ?] existing behaviours and attitudes, enabling them to effectively manage and support patients with chronic oedema.
The changes in patients' EQ-5D 5L scores before and after they received the OGEP requires consideration. While these effect sizes are small, they indicate improvements were made in patients' health-related quality of life, which requires further study. The major caveat [Q is this referring to the lack of a comparator group?] to any interpretation in the context of this pilot service evaluation precluded any rigorous comparative analysis of the costeffectiveness of the OGEP. This pilot service evaluation is the first step in determining the effects of the OGEP model and offers valuable information about its potential benefits.
Limitations
Since the pilot evaluation was based on a service innovation delivered within routine clinical practice, the project design was limited in several areas, particularly the lack of comparator, for example a matched control site or cohort of patients who did not receive the OGEP.
It is important to note that not all of the benefits may be directly linked to the OGEP. In the pilot service evaluation, the costs at the start (before the OGEP) may have been escalated because of the complex nature of chronic oedema [Q I'm not sure why this would've changed? The nature of chronic oedema would still be complexare you saying its more complex when it is initially identified/diagnosed than when treatment has commenced?]. In addition, only six months of activity were captured in this pilot service evaluation.
Economic analysis ultimately relies on the strength of the evaluation design and quality of data received, and the pilot service evaluation was undertaken in full acknowledgement of these constraints.
Conclusion
The prevalence of chronic oedema is increasing, and is frequently unrecognised and treated inappropriately, compounded by the lack of standardised care pathways for managing chronic oedema and wet legs. Demands on the community nursing services are also escalating; therefore, new ways of providing nurse education should be investigated. Potential benefits to patients' quality of life and reductions in NHS costs and could be achieved through improved education and training for community nurses in the management of chronic oedema. This pilot service evaluation provided an in-depth examination of the effects that the OGEP could have in providing an innovative solution to delivering best practice care for these patients. While the findings suggest an observed trend for reductions in costs and patient benefits, further research over a longer period is required.
Implications for practice
 Improvements to the quality of life for patients with chronic oedema have been identified.
 Policymakers and commissioners should be made aware of the potential reductions and improvements to patients' quality of life that could be made by the implementing the OGEP.
 Education providers should consider the importance of chronic oedema management in pre and post-registration courses for general and specialist nursing.
 Lymphoedema Network Wales is investigating the expansion of the OGEP across other health boards.
